Search for: "William E Drew"
Results 201 - 209
of 209
Sorted by Relevance
|
Sort by Date
5 Jul 2023, 3:51 am
In Chewy v. [read post]
15 Sep 2023, 6:00 am
The other key U.S. figure who promoted the worldwide development of sound competition-law standards was George Washington University Law School’s William Kovacic, who later served as FTC’s general counsel, a commissioner from 2006 to 2011, and chair of the commission from 2008 to 2009. [read post]
16 Jul 2021, 12:00 am
Effort to Learn Source of Leaks for Post Stories Came in Barr’s Final Days as AG, Court Documents Show MSN – Devlin Barrett and Spencer Hsu (Washington Post) | Published: 7/13/2021 Newly unsealed court documents show the Justice Department under Donald Trump sought a court order for the communications records of three Washington Post reporters in the final days of William Barr’s tenure as attorney general in 2020, as prosecutors sought to identify sources for three… [read post]
23 Feb 2024, 3:00 am
National/Federal The Quiet Way Democrats Hope to Expand Their Power at the State Level DNyuz – Nick Corasaniti (New York Times) | Published: 2/20/2024 Locked out of power on the U.S. [read post]
23 Oct 2019, 8:36 am
William Montross, counsel for defendant Walid bin Attash, argued that capital cases demand due process and that it was essential under relevant case law that Reismeier be disinterested and not even appear partial. [read post]
26 May 2022, 10:49 am
As previewed in the sentence I quoted at (c), Alito affirms that the common law drew "a distinction between pre- and post-quickening abortions" and that it didn't generally treat pre-quickening abortions as crimes. [read post]
3 Apr 2020, 12:00 am
Drew Hinshaw & Catherine Luckey, U.S. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
